Zollinger-Ellison syndrome differential diagnosis: Difference between revisions

Jump to navigation Jump to search
Line 16: Line 16:




{| style="border: 0px; font-size: 110%; margin: 3px;" align="center"
{| style="border: 0px; font-size: 100%; margin: 3px;" align="center"
| colspan="3" style="background: #4479BA; text-align: center;" | {{fontcolor|#FFF|'''Differential diagnosis of Hypergastrinemia'''}}
| colspan="3" style="background: #4479BA; text-align: center;" | {{fontcolor|#FFF|'''Differential diagnosis of Hypergastrinemia'''}}
|+
|+
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #DCDCDC; font-weight: bold;" rowspan="2;" |
*Gastrinoma
*Gastrinoma
*Gastric outlet obstruction
*Gastric outlet obstruction

Revision as of 16:51, 3 August 2017

Zollinger-Ellison syndrome Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Zollinger-Ellison syndrome from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-ray

Echocardiography and Ultrasound

CT scan

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Zollinger-Ellison syndrome differential diagnosis On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Zollinger-Ellison syndrome differential diagnosis

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Zollinger-Ellison syndrome differential diagnosis

CDC on Zollinger-Ellison syndrome differential diagnosis

Zollinger-Ellison syndrome differential diagnosis in the news

Blogs on Zollinger-Ellison syndrome differential diagnosis

Directions to Hospitals Treating Zollinger-Ellison syndrome

Risk calculators and risk factors for Zollinger-Ellison syndrome differential diagnosis

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Mohamad Alkateb, MBBCh [2]

Overview

Zollinger-Ellison syndrome must be differentiated from gastric antrum syndrome, antral G-cell hyperplasia, peptic ulcer, gastroesophageal reflux disease (GERD), and hypergastrinemia.

Differentiating Zollinger-Ellison syndrome from other Diseases

Zollinger-Ellison syndrome must be differentiated from:[1]

Differential diagnosis of hypergastrinemia

Differential diagnosis of Hypergastrinemia
  • Gastrinoma
  • Gastric outlet obstruction
  • Retained antrum syndrome
  • Previous vagotomy
  • Antral G cell hyperplasia/hyperfunction
  • Pernicious anemia
  • Atrophic gastritis
  • Short gut syndrome
  • Renal Failure

References

  1. SCOBIE BA, MCGILL DB, PRIESTLEY JT, ROVELSTAD RA (1964). "EXCLUDED GASTRIC ANTRUM SIMULATING THE ZOLLINGER-ELLISON SYNDROME". Gastroenterology. 47: 184–7. PMID 14201408.

Template:WH Template:WS